Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY12 | Q9H244 | 3/20 | 0.44 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.43 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.43 |
| ▸ | DNPH1 | O43598 | 2/20 | 0.42 |
| ▸ | NT5E | P21589 | 1/20 | 0.40 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19146858 | 0.87 | P2RY12 (0.52) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL19146240 | 0.83 | P2RY12 (0.45) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL19146392 | 0.81 | P2RY12 (0.42) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL20026293 | 0.81 | P2RY12 (0.43) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL18496467 | 0.80 | SLC29A1 (0.59) | SLC29A1 | |
| SCHEMBL31160198 | 0.80 | SLC29A1 (0.59) | SLC29A1 | |
| SCHEMBL20353076 | 0.79 | P2RY12 (0.45) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL19145868 | 0.79 | P2RY12 (0.40) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL9023774 | 0.79 | P2RY12 (0.49) | P2RY12P2RY2P2RY1P2RY6DNPH1 | |
| SCHEMBL19146535 | 0.78 | ADORA1 (0.37) | P2RY12P2RY2P2RY1P2RY6PRMT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017123669-A1 | CYCLIC DINUCLEOTIDES FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY SUCH AS CANCER | GLICK GARY (US) | 2017-07-20 | — | — | WO | disclosed |